HNL News

December 06, 2022

Oncomine Myeloid Assay Coming Soon!

Myeloid malignancies are clonal diseases with multiple known genetic mutations. Genomic sequencing is advantageous in the classification and treatment of these diseases and can now be performed with a single test.

Read More
November 18, 2022

RSV Surge Continues, Putting Infants at Risk

Cases of RSV, or respiratory syncytial virus, are surging in the United States at rates far higher and earlier than expected. RSV-associated hospitalizations have more than doubled compared to last season¹. Download RSV| The Surge Continues, Putting Infants at Risk Infographic
Read More
November 17, 2022

A Day in the Life of an HNL Lab Medicine Courier

Are you curious about what a day in the life of an HNL Lab Medicine Courier is like?   
Read More
November 14, 2022

November is Lung Cancer Awareness Month

Lung cancer is responsible for the highest number of cancer deaths with an estimated 130,180 deaths each year¹.

Read More
November 10, 2022

World Diabetes Day

Over 34 million Americans have diabetes, there is a good chance that you or someone you know is living with diabetes¹. But what about people who don’t know?
Read More
Healthcare Professionals

COVID-19 Information

COVID 19 ICD 10 Coding and Insurance Reporting Guidelines 2022

2022 ICD-10-CM Code Update Announced
2022 ICD-10-CM code updates were made publicly available by the Center for Disease Control and Prevention (CDC) on Dec. 1, 2021. Diagnosis codes of interest to laboratory and pathology practices includes the addition of three new codes for documenting immunization status effective for dates of service on or after April 1, 2022:
 
  • Z28.310-Unvaccinated for COVID-19 (Use this code when the patient has not received at least one dose of any COVID-19 vaccine. Effective for dates of service on or after April 1, 2022.)
     
  • Z28.311-Partially vaccinated for COVID-19 (Use this code when the patient has received at least one dose of a multi-dose COVID-19 vaccine regimen but has not received the full set of doses necessary to meet the CDC definition of “fully vaccinated” in place at the time of encounter. Effective for dates of service on or after April 1, 2022.)
     
  • Z28.39-Other under immunization status (Use this code for delinquent or lapsed immunization status. Effective for dates of service on or after April 1, 2022.)
COVID-19 Testing for Uninsured Patients (Cares Act Guidelines)

Professional and Facility Providers

 
  • COVID Screening Tests (Z11.52 and Z11.59)
    As a reminder, during the national Public Health Emergency (PHE) and consistent with the Centers for Disease Control and Prevention (CDC) guidelines, Capital Blue Cross health plans will cover the cost of a COVID-19 diagnostic test without applying member cost share (such as deductibles, copays, and coinsurance) if performed as a result of an individualized clinical assessment, such as a test ordered by a provider or when a provider refers the member for a test. However, Capital will not provide coverage of testing for public health surveillance or employment purposes.

    Effective July 1, 2022, claims submitted with a COVID testing procedure code with a diagnosis code indicative of encounter for screening for other viral diseases (Z11.52 and Z11.59) will deny as not covered.

    Administrative Notice AN2022-06-002 (capbluecross.com)